Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial
- Houyu Ju
- Yunteng Wu
- Chaoji Shi
- Ronghui Xia
- Hao Song
- Xuhui Ma
- Yang Liu
- Lulu Sun
- Ling Zhu
- Lingyan Chen
- Shuyang Sun
- Yue He
- Guoxin Ren
- Jingzhou Hu
2026-01-28